EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced CRISPR‐cas systems for genome editing and molecular diagnostics

Sheng Li, Han Li, Bojie Chen, Ling Jiang, Keyu Long, Jiaqi Lang, Xingxiang Pu, Erhu Xiong

Interdisciplinary Medicine · 12.07.2026

DOI: 10.1002/inmd.70162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interdisciplinary Medicine, online erschienen am 12.07.2026. Verfasst von Sheng Li und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR‐Cas systems have far‐reaching implications for genome editing and molecular diagnostics, and are emerging as important tools in biomedical research and clinical practice. These systems enable precise genetic manipulation and highly sensitive nucleic acid detection, capabilities that are invaluable for therapeutic development and pathogen surveillance. Nevertheless, native CRISPR‐Cas systems possess inherent limitations that constrain their broader utility. These limitations in genome editing include insufficient editing efficiency, a restricted range of targets due to protospacer adjacent motif constraints and non‐negligible off‐target effects. In molecular diagnostics, the remaining problems include detecting low‐abundance targets, achieving high specificity, and ensuring effective compatibility with isothermal amplification. To address these limitations, researchers have proposed many enhancement strategies that mainly center around four aspects: engineering of Cas effector protein, optimizing guide RNA designs, developing advanced reporter probes, and utilizing chemical additives. This review summarizes the current developments in these areas and highlights their significant contribution to increasing the fidelity of editing and diagnostic sensitivity. In addition, we discuss future prospects for enhanced CRISPR‐Cas systems, focusing on their accelerating clinical translation and expanding biomedical applications.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, S., Li, H., Chen, B., Jiang, L., Long, K., Lang, J., Pu, X., & Xiong, E. (2026). Enhanced CRISPR‐cas systems for genome editing and molecular diagnostics. Interdisciplinary Medicine. https://doi.org/10.1002/inmd.70162

Vancouver

Li S, Li H, Chen B, Jiang L, Long K, Lang J, et al. Enhanced CRISPR‐cas systems for genome editing and molecular diagnostics. Interdisciplinary Medicine. 2026. doi:10.1002/inmd.70162

BibTeX
@article{Li2026,
  author = {Li, Sheng and Li, Han and Chen, Bojie and Jiang, Ling and Long, Keyu and Lang, Jiaqi and Pu, Xingxiang and Xiong, Erhu},
  title = {Enhanced CRISPR‐cas systems for genome editing and molecular diagnostics},
  journal = {Interdisciplinary Medicine},
  year = {2026},
  doi = {10.1002/inmd.70162}
}
Kostenlos starten →